These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2366154)

  • 1. Pediatric psychopharmacologic uses of propranolol. Review and case illustrations.
    Sims J; Galvin MR
    J Child Adolesc Psychiatr Ment Health Nurs; 1990; 3(1):18-24. PubMed ID: 2366154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of propranolol to decrease aggressive outbursts in younger patients. Open study reveals potentially favorable outcome.
    Kuperman S; Stewart MA
    Psychosomatics; 1987 Jun; 28(6):315-9. PubMed ID: 3432546
    [No Abstract]   [Full Text] [Related]  

  • 3. Juvenile maladaptive aggression: a review of prevention, treatment, and service configuration and a proposed research agenda.
    Connor DF; Carlson GA; Chang KD; Daniolos PT; Ferziger R; Findling RL; Hutchinson JG; Malone RP; Halperin JM; Plattner B; Post RM; Reynolds DL; Rogers KM; Saxena K; Steiner H;
    J Clin Psychiatry; 2006 May; 67(5):808-20. PubMed ID: 16841631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol treatment of assaultive patients with organic brain disease. A double-blind crossover, placebo-controlled study.
    Greendyke RM; Kanter DR; Schuster DB; Verstreate S; Wootton J
    J Nerv Ment Dis; 1986 May; 174(5):290-4. PubMed ID: 3517228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol treatment of episodic dyscontrol and aggressive behavior in children.
    Grizenko N; Vida S
    Can J Psychiatry; 1988 Nov; 33(8):776-8. PubMed ID: 3203281
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychopharmacology of temper outbursts. A review.
    Mattes JA
    J Nerv Ment Dis; 1986 Aug; 174(8):464-70. PubMed ID: 3525749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose propranolol reduces aggression and agitation resembling that associated with orbitofrontal dysfunction in elderly demented patients.
    Shankle WR; Nielson KA; Cotman CW
    Alzheimer Dis Assoc Disord; 1995; 9(4):233-7. PubMed ID: 8749613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
    Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
    J Cutan Med Surg; 2012; 16(5):317-23. PubMed ID: 22971306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic use of propranolol for intermittent explosive disorder.
    Jenkins SC; Maruta T
    Mayo Clin Proc; 1987 Mar; 62(3):204-14. PubMed ID: 3546964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol for the control of belligerent behavior following acute brain damage.
    Elliott FA
    Ann Neurol; 1977 May; 1(5):489-91. PubMed ID: 617263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial experience using propranolol as an adjunctive treatment in children with aggressive recurrent respiratory papillomatosis.
    Maturo S; Tse SM; Kinane TB; Hartnick CJ
    Ann Otol Rhinol Laryngol; 2011 Jan; 120(1):17-20. PubMed ID: 21370676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol in the treatment of postencephalitic psychosis.
    Abraham G; Jarrett F
    Can J Psychiatry; 1990 Feb; 35(1):104-5. PubMed ID: 2317730
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of propranolol on conversational reciprocity in autism spectrum disorder: a pilot, double-blind, single-dose psychopharmacological challenge study.
    Zamzow RM; Ferguson BJ; Stichter JP; Porges EC; Ragsdale AS; Lewis ML; Beversdorf DQ
    Psychopharmacology (Berl); 2016 Apr; 233(7):1171-8. PubMed ID: 26762378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
    Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
    J Cutan Med Surg; 2012; 16(2):115-21. PubMed ID: 22513064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol in ataxia and in aggression: central actions.
    LeFever FF
    Arch Neurol; 1986 Jan; 43(1):9. PubMed ID: 3942526
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical pharmacology of aggressive behavior.
    Sheard MH
    Clin Neuropharmacol; 1984; 7(3):173-83. PubMed ID: 6149018
    [No Abstract]   [Full Text] [Related]  

  • 17. Propranolol palliation of tetralogy of Fallot: experience with long-term drug treatment in pediatric patients.
    Ponce FE; Williams LC; Webb HM; Riopel DA; Hohn AR
    Pediatrics; 1973 Jul; 52(1):100-8. PubMed ID: 4125077
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral propranolol treatment in infants and children.
    Gillette P; Garson A; Eterovic E; Neches W; Mullins C; McNamara DG
    J Pediatr; 1978 Jan; 92(1):141-4. PubMed ID: 619057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of recombinant human growth hormone and propranolol decreases hypermetabolism and inflammation in severely burned children.
    Jeschke MG; Finnerty CC; Kulp GA; Przkora R; Mlcak RP; Herndon DN
    Pediatr Crit Care Med; 2008 Mar; 9(2):209-16. PubMed ID: 18477935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium and propranolol in aggression and self-injurious behavior in the mentally retarded.
    Luchins DJ; Dojka D
    Psychopharmacol Bull; 1989; 25(3):372-5. PubMed ID: 2626515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.